Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
2.
Environ Sci Pollut Res Int ; 29(47): 70909-70920, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-35595893

RESUMO

Paraquat is a highly toxic and persistent pesticide in soil but is still used for wheat crops in many countries. Paraquat can pose potential health hazards if it is translocated from soil into wheat grains, but no study is available for its possible translocation causing wheat grain contamination. The present study aimed at finding out Paraquat residue in wheat grains under field conditions for two crop seasons to explore the sustainability of this pesticide. The experiments were conducted scientifically under field conditions at agricultural fields Pusa, Delhi, India. The soil texture was classified as sandy loam. Paraquat dichloride 24% SL (herbicide) was applied on five fields except for control field. Paraquat in wheat grains was analyzed using HPLC equipped with a photodiode array (PDA) detector. The method of analysis was validated for the pesticide residue recovery. The results showed that there was an alarming concentration of Paraquat in wheat grains ranging between 21.6 and 49.02 mg kg-1 against maximum residue level of 0.1 mg kg-1. Paraquat was also found in control crop (3.1 mg kg-1) due to background residue in soil even when no Paraquat was applied. Furthermore, wheat flour samples from market also gave alarming Paraquat residue (20.39, 25.88, and 27.68 mg kg-1). Paraquat residue was primarily dependent on % clay in field soils. More the % clay lesser was Paraquat residue in wheat grain. Thus, Paraquat was translocated from soil into wheat grains and resulted in worrying concentration of Paraquat residue in wheat grains. Consequently, use of Paraquat for wheat crops needs to be regulated as it contaminated the soil and resulted in the wheat grain contamination posing severe health hazards for humans.


Assuntos
Herbicidas , Resíduos de Praguicidas , Poluentes do Solo , Argila , Produtos Agrícolas , Grão Comestível/química , Farinha/análise , Herbicidas/análise , Humanos , Paraquat , Resíduos de Praguicidas/análise , Solo/química , Poluentes do Solo/análise , Triticum/química
3.
J Clin Neonatol ; 2(3): 146-8, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24251262

RESUMO

Pulmonary sequestration is a rare malformation, wherein a portion of lung is non-functional and is not in normal continuity with the tracheo-bronchial tree, and may derive its blood supply from systemic vessels. Two types are described: Intralobar and extralobar types. Intralobar sequestration is more common type, which shares visceral pleura of the involved lobe and is localized within the normal pulmonary parenchyma. Whereas extralobar forms are uncommon and are totally separate from the lung and usually have own covering. Infra-diaphragmatic pulmonary sequestration is of extralobar type and is extremely rare, and usually is associated with other congenital malformations. We present an extremely rare case of isolated infra-diaphragmatic pulmonary sequestration which was antenatally detected and followed up with postnatal CT scan, where it masqueraded as suprarenal mass, and was surgically treated. This case emphasises to add a differential diagnosis of malformation in congenital supra-renal masses, which remain stable in size and appearance, and hence avoid immediate surgery.

4.
AIDS Res Treat ; 2012: 412643, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22611485

RESUMO

In 2009, Government of Kenya with key stakeholders implemented an integrated multi-disease prevention campaign for water-borne diseases, malaria and HIV in Kisii District, Nyanza Province. The three day campaign, targeting 5000 people, included testing and counseling (HTC), condoms, long-lasting insecticide-treated bednets, and water filters. People with HIV were offered on-site CD4 cell counts, condoms, co-trimoxazole, and HIV clinic referral. We analysed the CD4 distributions from a district hospital cohort, campaign participants and from the 2007 Kenya Aids Indicator Survey (KAIS). Of the 5198 individuals participating in the campaign, all received HTC, 329 (6.3%) tested positive, and 255 (5%) were newly diagnosed (median CD4 cell count 536 cells/µL). The hospital cohort and KAIS results included 1,284 initial CD4 counts (median 348/L) and 306 initial CD4 counts (median 550/µL), respectively (campaign and KAIS CD4 distributions P = 0.346; hospital cohort distribution was lower P < 0.001 and P < 0.001). A Nyanza Province campaign strategy including ART <350 CD4 cell count could avert approximately 35,000 HIV infections and 1,240 TB cases annually. Community-based integrated public health campaigns could be a potential solution to reach universal access and Millennium Development Goals.

5.
PLoS One ; 7(2): e30216, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22348000

RESUMO

BACKGROUND: Antiretroviral Treatment (ART) significantly reduces HIV transmission. We conducted a cost-effectiveness analysis of the impact of expanded ART in South Africa. METHODS: We model a best case scenario of 90% annual HIV testing coverage in adults 15-49 years old and four ART eligibility scenarios: CD4 count <200 cells/mm(3) (current practice), CD4 count <350, CD4 count <500, all CD4 levels. 2011-2050 outcomes include deaths, disability adjusted life years (DALYs), HIV infections, cost, and cost per DALY averted. Service and ART costs reflect South African data and international generic prices. ART reduces transmission by 92%. We conducted sensitivity analyses. RESULTS: Expanding ART to CD4 count <350 cells/mm(3) prevents an estimated 265,000 (17%) and 1.3 million (15%) new HIV infections over 5 and 40 years, respectively. Cumulative deaths decline 15%, from 12.5 to 10.6 million; DALYs by 14% from 109 to 93 million over 40 years. Costs drop $504 million over 5 years and $3.9 billion over 40 years with breakeven by 2013. Compared with the current scenario, expanding to <500 prevents an additional 585,000 and 3 million new HIV infections over 5 and 40 years, respectively. Expanding to all CD4 levels decreases HIV infections by 3.3 million (45%) and costs by $10 billion over 40 years, with breakeven by 2023. By 2050, using higher ART and monitoring costs, all CD4 levels saves $0.6 billion versus current; other ART scenarios cost $9-194 per DALY averted. If ART reduces transmission by 99%, savings from all CD4 levels reach $17.5 billion. Sensitivity analyses suggest that poor retention and predominant acute phase transmission reduce DALYs averted by 26% and savings by 7%. CONCLUSION: Increasing the provision of ART to <350 cells/mm3 may significantly reduce costs while reducing the HIV burden. Feasibility including HIV testing and ART uptake, retention, and adherence should be evaluated.


Assuntos
Fármacos Anti-HIV/economia , Infecções por HIV/prevenção & controle , Fármacos Anti-HIV/uso terapêutico , Contagem de Linfócito CD4 , Análise Custo-Benefício/tendências , Custos e Análise de Custo/tendências , Previsões , Infecções por HIV/tratamento farmacológico , Infecções por HIV/economia , Humanos , África do Sul
6.
BMC Health Serv Res ; 11: 346, 2011 Dec 21.
Artigo em Inglês | MEDLINE | ID: mdl-22189090

RESUMO

BACKGROUND: Delivery of community-based prevention services for HIV, malaria, and diarrhea is a major priority and challenge in rural Africa. Integrated delivery campaigns may offer a mechanism to achieve high coverage and efficiency. METHODS: We quantified the resources and costs to implement a large-scale integrated prevention campaign in Lurambi Division, Western Province, Kenya that reached 47,133 individuals (and 83% of eligible adults) in 7 days. The campaign provided HIV testing, condoms, and prevention education materials; a long-lasting insecticide-treated bed net; and a water filter. Data were obtained primarily from logistical and expenditure data maintained by implementing partners. We estimated the projected cost of a Scaled-Up Replication (SUR), assuming reliance on local managers, potential efficiencies of scale, and other adjustments. RESULTS: The cost per person served was $41.66 for the initial campaign and was projected at $31.98 for the SUR. The SUR cost included 67% for commodities (mainly water filters and bed nets) and 20% for personnel. The SUR projected unit cost per person served, by disease, was $6.27 for malaria (nets and training), $15.80 for diarrhea (filters and training), and $9.91 for HIV (test kits, counseling, condoms, and CD4 testing at each site). CONCLUSIONS: A large-scale, rapidly implemented, integrated health campaign provided services to 80% of a rural Kenyan population with relatively low cost. Scaling up this design may provide similar services to larger populations at lower cost per person.


Assuntos
Relações Comunidade-Instituição , Prestação Integrada de Cuidados de Saúde/economia , Diarreia/prevenção & controle , Infecções por HIV/prevenção & controle , Promoção da Saúde/métodos , Malária/prevenção & controle , Diarreia/economia , Infecções por HIV/economia , Coalizão em Cuidados de Saúde , Promoção da Saúde/economia , Humanos , Quênia , População Rural
7.
Curr HIV Res ; 9(6): 416-28, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21999777

RESUMO

Expanding access to antiretroviral therapy (ART) has both individual health benefits and potential to decrease HIV incidence. Ensuring access to HIV services is a significant human rights issue and successful programmes require adequate human rights protections and community support. However, the cost of specific human rights and community support interventions for equitable, sustainable and non-discriminatory access to ART are not well described. Human rights and community support interventions were identified using the literature and through consultations with experts. Specific costs were then determined for these health sector interventions. Population and epidemic data were provided through the Statistics South Africa 2009 national mid-year estimates. Costs of scale up of HIV prevention and treatment were taken from recently published estimates. Interventions addressed access to services, minimising stigma and discrimination against people living with HIV, confidentiality, informed consent and counselling quality. Integrated HIV programme interventions included training for counsellors, 'Know Your Rights' information desks, outreach campaigns for most at risk populations, and adherence support. Complementary measures included post-service interviews, human rights abuse monitoring, transportation costs, legal assistance, and funding for human rights and community support organisations. Other essential non-health sector interventions were identified but not included in the costing framework. The annual costs for the human rights and community support interventions are United States (US) $63.8 million (US $1.22 per capita), representing 1.5% of total health sector HIV programme costs. Respect for human rights and community engagement can be understood both as an obligation of expanded ART programmes and as a critically important factor in their success. Basic rights-based and community support interventions constitute only a small percentage of overall programmes costs. ART programs should consider measuring the cost and impact of human rights and community support interventions as key aspects of successful programme expansion.


Assuntos
Terapia Antirretroviral de Alta Atividade/economia , Serviços de Saúde Comunitária/economia , Infecções por HIV/economia , Infecções por HIV/terapia , Acessibilidade aos Serviços de Saúde/economia , Direitos Humanos , Apoio Social , Custos e Análise de Custo , Prestação Integrada de Cuidados de Saúde/economia , Humanos , África do Sul
8.
PLoS One ; 5(8): e12435, 2010 Aug 26.
Artigo em Inglês | MEDLINE | ID: mdl-20865049

RESUMO

BACKGROUND: Integrated disease prevention in low resource settings can increase coverage, equity and efficiency in controlling high burden infectious diseases. A public-private partnership with the Ministry of Health, CDC, Vestergaard Frandsen and CHF International implemented a one-week integrated multi-disease prevention campaign. METHOD: Residents of Lurambi, Western Kenya were eligible for participation. The aim was to offer services to at least 80% of those aged 15-49. 31 temporary sites in strategically dispersed locations offered: HIV counseling and testing, 60 male condoms, an insecticide-treated bednet, a household water filter for women or an individual filter for men, and for those testing positive, a 3-month supply of cotrimoxazole and referral for follow-up care and treatment. FINDINGS: Over 7 days, 47,311 people attended the campaign with a 96% uptake of the multi-disease preventive package. Of these, 99.7% were tested for HIV (87% in the target 15-49 age group); 80% had previously never tested. 4% of those tested were positive, 61% were women (5% of women and 3% of men), 6% had median CD4 counts of 541 cell/µL (IQR; 356, 754). 386 certified counselors attended to an average 17 participants per day, consistent with recommended national figures for mass campaigns. Among women, HIV infection varied by age, and was more likely with an ended marriage (e.g. widowed vs. never married, OR.3.91; 95% CI. 2.87-5.34), and lack of occupation. In men, quantitatively stronger relationships were found (e.g. widowed vs. never married, OR.7.0; 95% CI. 3.5-13.9). Always using condoms with a non-steady partner was more common among HIV-infected women participants who knew their status compared to those who did not (OR.5.4 95% CI. 2.3-12.8). CONCLUSION: Through integrated campaigns it is feasible to efficiently cover large proportions of eligible adults in rural underserved communities with multiple disease preventive services simultaneously achieving various national and international health development goals.


Assuntos
Aconselhamento , Diarreia/prevenção & controle , Infecções por HIV/prevenção & controle , Infecções por HIV/psicologia , Promoção da Saúde , Malária/prevenção & controle , Adolescente , Adulto , Preservativos , Diarreia/tratamento farmacológico , Feminino , Infecções por HIV/diagnóstico , Infecções por HIV/tratamento farmacológico , Humanos , Quênia , Malária/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Parcerias Público-Privadas , População Rural , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA